Approval · Notice of Compliance 978 · 2000
AGRYLIN: Notice of Compliance 978
Issued March 3, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 978
- Date
- March 3, 2000
- Company
- Shire Canada IncLaval, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Platelet-reducing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AGRYLIN | 02236859 | Cancelled Post Market |
| AGRYLIN | 02236860 | — |
Medicinal ingredients
- ANAGRELIDE HYDROCHLORIDE 0.5 MG per CAP
- ANAGRELIDE HYDROCHLORIDE 1 MG per CAP